» Articles » PMID: 39319345

General Control Nonderepressible 2 (GCN2) As a Therapeutic Target in Age-related Diseases

Overview
Journal Front Aging
Specialty Geriatrics
Date 2024 Sep 25
PMID 39319345
Authors
Affiliations
Soon will be listed here.
Abstract

The function of General Control Nonderepressible 2 (GCN2), an evolutionary-conserved component of the integrated stress response (ISR), has been well-documented across organisms from yeast to mammals. Recently GCN2 has also gained attention for its role in health and disease states. In this review, we provide a brief overview of GCN2, including its structure, activation mechanisms and interacting partners, and explore its potential significance as a therapeutic target in various age-related diseases including neurodegeneration, inflammatory disorders and cancer. Finally, we summarize the barriers to effectively targeting GCN2 for the treatment of disease and to promote a healthier aging process.

References
1.
Xu X, Hu J, McGrath B, Cavener D . GCN2 regulates the CCAAT enhancer binding protein beta and hepatic gluconeogenesis. Am J Physiol Endocrinol Metab. 2013; 305(8):E1007-17. PMC: 3798698. DOI: 10.1152/ajpendo.00063.2013. View

2.
Hu X, Niu Y, Luo P, Xiao F, Yuan F, Yin H . Amino acid sensor GCN2 promotes SARS-CoV-2 receptor ACE2 expression in response to amino acid deprivation. Commun Biol. 2022; 5(1):651. PMC: 9249868. DOI: 10.1038/s42003-022-03609-0. View

3.
Pochopien A, Beckert B, Kasvandik S, Berninghausen O, Beckmann R, Tenson T . Structure of Gcn1 bound to stalled and colliding 80S ribosomes. Proc Natl Acad Sci U S A. 2021; 118(14). PMC: 8040806. DOI: 10.1073/pnas.2022756118. View

4.
Bchir W, Maurin A, Carraro V, Averous J, Jousse C, Muranishi Y . The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013; 41(16):7683-99. PMC: 3763548. DOI: 10.1093/nar/gkt563. View

5.
Missiaen R, Anderson N, Kim L, Nance B, Burrows M, Skuli N . GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. Cell Metab. 2022; 34(8):1151-1167.e7. PMC: 9357184. DOI: 10.1016/j.cmet.2022.06.010. View